Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study

Kathryn Peebles, John E. Mittler, Steven M. Goodreau, James T. Murphy, Molly C. Reid, Neil Abernethy, Geoffrey S. Gottlieb, Ruanne V. Barnabas, Joshua T. Herbeck
doi: https://doi.org/10.1101/2020.12.13.20248146

Article usage

Article usage: December 2020 to June 2025

AbstractFullPdf
Dec 2020707386
Jan 2021404115
Feb 20217506
Mar 2021681311
Apr 202177139
May 20215425
Jun 20214607
Jul 20212627
Aug 20212465
Sep 202118113
Oct 202113124
Nov 202122019
Dec 20213012
Jan 20221524
Feb 20221301
Mar 20221604
Apr 20221802
May 20222209
Jun 20221515
Jul 20221001
Aug 20221112
Sep 20222526
Oct 20222217
Nov 2022803
Dec 2022814
Jan 20231264
Feb 20231274
Mar 2023811
Apr 20231611
May 20231026
Jun 2023741
Jul 2023401
Aug 202316134
Sep 20231341
Oct 2023531
Nov 20231051
Dec 20231213
Jan 2024401
Feb 20241004
Mar 20241327
Apr 2024564
May 2024515
Jun 2024823
Jul 20241113
Aug 2024613
Sep 2024933
Oct 2024462
Nov 2024713
Dec 2024200
Jan 2025612
Feb 20256224
Mar 202526379
Apr 20251014
May 2025949
Jun 2025422020
Back to top
Posted December 14, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Risk compensation after HIV-1 vaccination may accelerate viral adaptation and reduce cost-effectiveness: a modeling study
Kathryn Peebles, John E. Mittler, Steven M. Goodreau, James T. Murphy, Molly C. Reid, Neil Abernethy, Geoffrey S. Gottlieb, Ruanne V. Barnabas, Joshua T. Herbeck
medRxiv 2020.12.13.20248146; doi: https://doi.org/10.1101/2020.12.13.20248146
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area